Drug Search Results

Doxifluridine

Alternative Names: doxifluridine
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: DNA Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India | Korea | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Abnoba
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Doxifluridine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Gastrointestinal Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
AMC0102	P3	Completed	Gastrointestinal Cancer	2007-12-01

Recent News Events

Date	Type	Title
09/01/2023	PubMed	Doxifluridine versus Tegafur/Gimeracil/Oteracil (S-1) as adjuvant chemotherapy for patients with gastric cancer after gastrectomy: A propensity score-matched analysis.
08/30/2023	News Article	VR All-in-one Headset Market Key Players, Scope of the Report, Size Estimation, Target Audience, Recent Developments And Forecast
08/01/2023	PubMed	Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).
04/25/2023	PubMed	Optimizing ex vivo culture conditions to study human gut microbiome.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions